APO Research

APO RESEARCH · REPORT

Genetically Modified Animal Models

Selected research

Industry Growth & Trends

Global Genetically Modified Animal Models Industry Growth and Trends Forecast to 2032

Market perspective

According to APO Research, the global Genetically Modified Animal Models market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Genetically Modified Animal Models is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Genetically Modified Animal Models is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Genetically Modified Animal Models is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Genetically Modified Animal Models market include ModelOrg, GemPharmatech, Cyagen Biosciences, Biocytogen, JOINN, China Environmental Technology and Bioenergy, Charles River, Taconic Biosciences and GenOway, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Genetically Modified Animal Models market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Genetically Modified Animal Models market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Genetically Modified Animal Models market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Genetically Modified Animal Models.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Genetically Modified Animal Models market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Genetically Modified Animal Models Market by Company

ModelOrg

GemPharmatech

Cyagen Biosciences

Biocytogen

JOINN

China Environmental Technology and Bioenergy

Charles River

Taconic Biosciences

GenOway

CLEA Japan

Ozgene

InVivo Biosystems

Harbour BioMed

PolyGene

Genetically Modified Animal Models Segment by Type

Rodents

Non-Human Primates

Zebrafish

Others

Genetically Modified Animal Models Segment by Application

Universities

Hospitals

Pharmaceutical Companies

Others

Genetically Modified Animal Models Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genetically Modified Animal Models market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genetically Modified Animal Models and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genetically Modified Animal Models.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Genetically Modified Animal Models companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Genetically Modified Animal Models Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Genetically Modified Animal Models Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Genetically Modified Animal Models Market Share by Region (2021-2026) Table 4. Global Genetically Modified Animal Models Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Genetically Modified Animal Models Market Share by Region (2027-2032) Table 6. Global Genetically Modified Animal Models Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Genetically Modified Animal Models Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Genetically Modified Animal Models Market Size Share by Type (2021-2026) Table 9. Global Genetically Modified Animal Models Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Genetically Modified Animal Models Market Size Share Forecasted by Type (2027-2032) Table 11. North America Genetically Modified Animal Models Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Genetically Modified Animal Models Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Genetically Modified Animal Models Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Genetically Modified Animal Models Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Genetically Modified Animal Models Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Genetically Modified Animal Models Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Genetically Modified Animal Models Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Genetically Modified Animal Models Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Genetically Modified Animal Models Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Genetically Modified Animal Models Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Genetically Modified Animal Models Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Genetically Modified Animal Models Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Genetically Modified Animal Models Market Size Share by Application (2021-2026) Table 24. Global Genetically Modified Animal Models Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Genetically Modified Animal Models Market Size Share Forecasted by Application (2027-2032) Table 26. North America Genetically Modified Animal Models Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Genetically Modified Animal Models Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Genetically Modified Animal Models Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Genetically Modified Animal Models Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Genetically Modified Animal Models Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Genetically Modified Animal Models Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Genetically Modified Animal Models Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Genetically Modified Animal Models Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Genetically Modified Animal Models Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Genetically Modified Animal Models Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Genetically Modified Animal Models Industry Trends Table 37. Genetically Modified Animal Models Industry Drivers Table 38. Genetically Modified Animal Models Industry Opportunities and Challenges Table 39. Genetically Modified Animal Models Industry Restraints Table 40. Global Genetically Modified Animal Models Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Genetically Modified Animal Models Revenue Market Share by Company (2021-2026) Table 42. Global Genetically Modified Animal Models Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Genetically Modified Animal Models Key Company Headquarters & Area Served Table 44. Global Genetically Modified Animal Models Company, Product Type & Application Table 45. Global Genetically Modified Animal Models Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Genetically Modified Animal Models by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. ModelOrg Company Information Table 49. ModelOrg Business Overview Table 50. ModelOrg Genetically Modified Animal Models Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. ModelOrg Genetically Modified Animal Models Product Portfolio Table 52. ModelOrg Recent Development Table 53. GemPharmatech Company Information Table 54. GemPharmatech Business Overview Table 55. GemPharmatech Genetically Modified Animal Models Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. GemPharmatech Genetically Modified Animal Models Product Portfolio Table 57. GemPharmatech Recent Development Table 58. Cyagen Biosciences Company Information Table 59. Cyagen Biosciences Business Overview Table 60. Cyagen Biosciences Genetically Modified Animal Models Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Cyagen Biosciences Genetically Modified Animal Models Product Portfolio Table 62. Cyagen Biosciences Recent Development Table 63. Biocytogen Company Information Table 64. Biocytogen Business Overview Table 65. Biocytogen Genetically Modified Animal Models Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Biocytogen Genetically Modified Animal Models Product Portfolio Table 67. Biocytogen Recent Development Table 68. JOINN Company Information Table 69. JOINN Business Overview Table 70. JOINN Genetically Modified Animal Models Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. JOINN Genetically Modified Animal Models Product Portfolio Table 72. JOINN Recent Development Table 73. China Environmental Technology and Bioenergy Company Information Table 74. China Environmental Technology and Bioenergy Business Overview Table 75. China Environmental Technology and Bioenergy Genetically Modified Animal Models Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. China Environmental Technology and Bioenergy Genetically Modified Animal Models Product Portfolio Table 77. China Environmental Technology and Bioenergy Recent Development Table 78. Charles River Company Information Table 79. Charles River Business Overview Table 80. Charles River Genetically Modified Animal Models Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Charles River Genetically Modified Animal Models Product Portfolio Table 82. Charles River Recent Development Table 83. Taconic Biosciences Company Information Table 84. Taconic Biosciences Business Overview Table 85. Taconic Biosciences Genetically Modified Animal Models Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Taconic Biosciences Genetically Modified Animal Models Product Portfolio Table 87. Taconic Biosciences Recent Development Table 88. GenOway Company Information Table 89. GenOway Business Overview Table 90. GenOway Genetically Modified Animal Models Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. GenOway Genetically Modified Animal Models Product Portfolio Table 92. GenOway Recent Development Table 93. CLEA Japan Company Information Table 94. CLEA Japan Business Overview Table 95. CLEA Japan Genetically Modified Animal Models Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. CLEA Japan Genetically Modified Animal Models Product Portfolio Table 97. CLEA Japan Recent Development Table 98. Ozgene Company Information Table 99. Ozgene Business Overview Table 100. Ozgene Genetically Modified Animal Models Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Ozgene Genetically Modified Animal Models Product Portfolio Table 102. Ozgene Recent Development Table 103. InVivo Biosystems Company Information Table 104. InVivo Biosystems Business Overview Table 105. InVivo Biosystems Genetically Modified Animal Models Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. InVivo Biosystems Genetically Modified Animal Models Product Portfolio Table 107. InVivo Biosystems Recent Development Table 108. Harbour BioMed Company Information Table 109. Harbour BioMed Business Overview Table 110. Harbour BioMed Genetically Modified Animal Models Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Harbour BioMed Genetically Modified Animal Models Product Portfolio Table 112. Harbour BioMed Recent Development Table 113. PolyGene Company Information Table 114. PolyGene Business Overview Table 115. PolyGene Genetically Modified Animal Models Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. PolyGene Genetically Modified Animal Models Product Portfolio Table 117. PolyGene Recent Development Table 118. North America Genetically Modified Animal Models Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America Genetically Modified Animal Models Market Size by Country (2021-2026) & (US$ Million) Table 120. North America Genetically Modified Animal Models Market Share by Country (2021-2026) Table 121. North America Genetically Modified Animal Models Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America Genetically Modified Animal Models Market Share Forecast by Country (2027-2032) Table 123. Europe Genetically Modified Animal Models Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe Genetically Modified Animal Models Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe Genetically Modified Animal Models Market Share by Country (2021-2026) Table 126. Europe Genetically Modified Animal Models Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe Genetically Modified Animal Models Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Genetically Modified Animal Models Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Genetically Modified Animal Models Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific Genetically Modified Animal Models Market Share by Country (2021-2026) Table 131. Asia-Pacific Genetically Modified Animal Models Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific Genetically Modified Animal Models Market Share Forecast by Country (2027-2032) Table 133. Latin America Genetically Modified Animal Models Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America Genetically Modified Animal Models Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America Genetically Modified Animal Models Market Share by Country (2021-2026) Table 136. Latin America Genetically Modified Animal Models Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America Genetically Modified Animal Models Market Share Forecast by Country (2027-2032) Table 138. Middle East & Africa Genetically Modified Animal Models Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Middle East & Africa Genetically Modified Animal Models Market Size by Country (2021-2026) & (US$ Million) Table 140. Middle East & Africa Genetically Modified Animal Models Market Share by Country (2021-2026) Table 141. Middle East & Africa Genetically Modified Animal Models Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Middle East & Africa Genetically Modified Animal Models Market Share Forecast by Country (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Genetically Modified Animal Models Product Image Figure 3. Global Genetically Modified Animal Models Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 5. Global Genetically Modified Animal Models Market Share by Region: 2025 VS 2032 Figure 6. Global Genetically Modified Animal Models Market Share by Region (2021-2032) Figure 7. North America Genetically Modified Animal Models Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Genetically Modified Animal Models Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Genetically Modified Animal Models Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Genetically Modified Animal Models Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Genetically Modified Animal Models Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Rodents Image Figure 13. Global Rodents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Non-Human Primates Image Figure 15. Global Non-Human Primates Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Zebrafish Image Figure 17. Global Zebrafish Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Genetically Modified Animal Models Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Genetically Modified Animal Models Market Share by Type 2025 VS 2032 Figure 22. North America Genetically Modified Animal Models Market Size Share by Type (2021-2032) Figure 23. Europe Genetically Modified Animal Models Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Genetically Modified Animal Models Market Size Share by Type (2021-2032) Figure 25. Latin America Genetically Modified Animal Models Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Genetically Modified Animal Models Market Size Share by Type (2021-2032) Figure 27. Universities Image Figure 28. Global Universities Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Hospitals Image Figure 30. Global Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Pharmaceutical Companies Image Figure 32. Global Pharmaceutical Companies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Others Image Figure 34. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Genetically Modified Animal Models Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Genetically Modified Animal Models Market Share by Application 2025 VS 2032 Figure 37. North America Genetically Modified Animal Models Market Size Share by Application (2021-2032) Figure 38. Europe Genetically Modified Animal Models Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Genetically Modified Animal Models Market Size Share by Application (2021-2032) Figure 40. Latin America Genetically Modified Animal Models Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Genetically Modified Animal Models Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Genetically Modified Animal Models Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Genetically Modified Animal Models Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Genetically Modified Animal Models Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Genetically Modified Animal Models Market Share by Country (2021-2032) Figure 47. Europe Genetically Modified Animal Models Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Genetically Modified Animal Models Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Genetically Modified Animal Models Market Share by Country (2021-2032) Figure 50. Asia-Pacific Genetically Modified Animal Models Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Genetically Modified Animal Models Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Genetically Modified Animal Models Market Share by Country (2021-2032) Figure 53. Latin America Genetically Modified Animal Models Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Genetically Modified Animal Models Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Genetically Modified Animal Models Market Share by Country (2021-2032) Figure 56. Middle East & Africa Genetically Modified Animal Models Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Genetically Modified Animal Models Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Genetically Modified Animal Models Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Rodents
  • Non-Human Primates
  • Zebrafish
  • Others
Applications
  • Universities
  • Hospitals
  • Pharmaceutical Companies
  • Others
Companies covered
  • ModelOrg
  • GemPharmatech
  • Cyagen Biosciences
  • Biocytogen
  • JOINN
  • China Environmental Technology and Bioenergy
  • Charles River
  • Taconic Biosciences
  • GenOway
  • CLEA Japan
  • Ozgene
  • InVivo Biosystems
  • Harbour BioMed
  • PolyGene

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Genetically Modified Animal Models Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Genetically Modified Animal Models Market Size by Region (2021-2032)
  5. 1.4.1 Global Genetically Modified Animal Models Market Size by Region (2021-2026)
  6. 1.4.2 Global Genetically Modified Animal Models Market Size by Region (2027-2032)
  7. 1.5 Key Regions Genetically Modified Animal Models Market Size (2021-2032)
  8. 1.5.1 North America Genetically Modified Animal Models Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Genetically Modified Animal Models Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Genetically Modified Animal Models Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Genetically Modified Animal Models Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Genetically Modified Animal Models Market Size Growth Rate (2021-2032)
2 Genetically Modified Animal Models Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Rodents
  3. 2.1.2 Non-Human Primates
  4. 2.1.3 Zebrafish
  5. 2.1.4 Others
  6. 2.2 Global Genetically Modified Animal Models Market Size by Type
  7. 2.2.1 Global Genetically Modified Animal Models Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Genetically Modified Animal Models Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Genetically Modified Animal Models Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Genetically Modified Animal Models Market Size by Regions
  11. 2.3.1 North America Genetically Modified Animal Models Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Genetically Modified Animal Models Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Genetically Modified Animal Models Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Genetically Modified Animal Models Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Genetically Modified Animal Models Market Size Breakdown by Type (2021-2026)
3 Genetically Modified Animal Models Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Universities
  3. 3.1.2 Hospitals
  4. 3.1.3 Pharmaceutical Companies
  5. 3.1.4 Others
  6. 3.2 Global Genetically Modified Animal Models Market Size by Application
  7. 3.2.1 Global Genetically Modified Animal Models Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Genetically Modified Animal Models Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Genetically Modified Animal Models Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Genetically Modified Animal Models Market Size by Regions
  11. 3.3.1 North America Genetically Modified Animal Models Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Genetically Modified Animal Models Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Genetically Modified Animal Models Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Genetically Modified Animal Models Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Genetically Modified Animal Models Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Genetically Modified Animal Models Industry Trends
  2. 4.2 Genetically Modified Animal Models Industry Drivers
  3. 4.3 Genetically Modified Animal Models Industry Opportunities and Challenges
  4. 4.4 Genetically Modified Animal Models Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Genetically Modified Animal Models Revenue (2021-2026)
  2. 5.2 Global Genetically Modified Animal Models Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Genetically Modified Animal Models Key Company Headquarters & Area Served
  4. 5.4 Global Genetically Modified Animal Models Company, Product Type & Application
  5. 5.5 Global Genetically Modified Animal Models Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Genetically Modified Animal Models Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Genetically Modified Animal Models Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Genetically Modified Animal Models Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 ModelOrg
  2. 6.1.1 ModelOrg Company Information
  3. 6.1.2 ModelOrg Business Overview
  4. 6.1.3 ModelOrg Genetically Modified Animal Models Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 ModelOrg Genetically Modified Animal Models Product Portfolio
  6. 6.1.5 ModelOrg Recent Developments
  7. 6.2 GemPharmatech
  8. 6.2.1 GemPharmatech Company Information
  9. 6.2.2 GemPharmatech Business Overview
  10. 6.2.3 GemPharmatech Genetically Modified Animal Models Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 GemPharmatech Genetically Modified Animal Models Product Portfolio
  12. 6.2.5 GemPharmatech Recent Developments
  13. 6.3 Cyagen Biosciences
  14. 6.3.1 Cyagen Biosciences Company Information
  15. 6.3.2 Cyagen Biosciences Business Overview
  16. 6.3.3 Cyagen Biosciences Genetically Modified Animal Models Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Cyagen Biosciences Genetically Modified Animal Models Product Portfolio
  18. 6.3.5 Cyagen Biosciences Recent Developments
  19. 6.4 Biocytogen
  20. 6.4.1 Biocytogen Company Information
  21. 6.4.2 Biocytogen Business Overview
  22. 6.4.3 Biocytogen Genetically Modified Animal Models Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Biocytogen Genetically Modified Animal Models Product Portfolio
  24. 6.4.5 Biocytogen Recent Developments
  25. 6.5 JOINN
  26. 6.5.1 JOINN Company Information
  27. 6.5.2 JOINN Business Overview
  28. 6.5.3 JOINN Genetically Modified Animal Models Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 JOINN Genetically Modified Animal Models Product Portfolio
  30. 6.5.5 JOINN Recent Developments
  31. 6.6 China Environmental Technology and Bioenergy
  32. 6.6.1 China Environmental Technology and Bioenergy Company Information
  33. 6.6.2 China Environmental Technology and Bioenergy Business Overview
  34. 6.6.3 China Environmental Technology and Bioenergy Genetically Modified Animal Models Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 China Environmental Technology and Bioenergy Genetically Modified Animal Models Product Portfolio
  36. 6.6.5 China Environmental Technology and Bioenergy Recent Developments
  37. 6.7 Charles River
  38. 6.7.1 Charles River Company Information
  39. 6.7.2 Charles River Business Overview
  40. 6.7.3 Charles River Genetically Modified Animal Models Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Charles River Genetically Modified Animal Models Product Portfolio
  42. 6.7.5 Charles River Recent Developments
  43. 6.8 Taconic Biosciences
  44. 6.8.1 Taconic Biosciences Company Information
  45. 6.8.2 Taconic Biosciences Business Overview
  46. 6.8.3 Taconic Biosciences Genetically Modified Animal Models Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Taconic Biosciences Genetically Modified Animal Models Product Portfolio
  48. 6.8.5 Taconic Biosciences Recent Developments
  49. 6.9 GenOway
  50. 6.9.1 GenOway Company Information
  51. 6.9.2 GenOway Business Overview
  52. 6.9.3 GenOway Genetically Modified Animal Models Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 GenOway Genetically Modified Animal Models Product Portfolio
  54. 6.9.5 GenOway Recent Developments
  55. 6.10 CLEA Japan
  56. 6.10.1 CLEA Japan Company Information
  57. 6.10.2 CLEA Japan Business Overview
  58. 6.10.3 CLEA Japan Genetically Modified Animal Models Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 CLEA Japan Genetically Modified Animal Models Product Portfolio
  60. 6.10.5 CLEA Japan Recent Developments
  61. 6.11 Ozgene
  62. 6.11.1 Ozgene Company Information
  63. 6.11.2 Ozgene Business Overview
  64. 6.11.3 Ozgene Genetically Modified Animal Models Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Ozgene Genetically Modified Animal Models Product Portfolio
  66. 6.11.5 Ozgene Recent Developments
  67. 6.12 InVivo Biosystems
  68. 6.12.1 InVivo Biosystems Company Information
  69. 6.12.2 InVivo Biosystems Business Overview
  70. 6.12.3 InVivo Biosystems Genetically Modified Animal Models Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 InVivo Biosystems Genetically Modified Animal Models Product Portfolio
  72. 6.12.5 InVivo Biosystems Recent Developments
  73. 6.13 Harbour BioMed
  74. 6.13.1 Harbour BioMed Company Information
  75. 6.13.2 Harbour BioMed Business Overview
  76. 6.13.3 Harbour BioMed Genetically Modified Animal Models Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Harbour BioMed Genetically Modified Animal Models Product Portfolio
  78. 6.13.5 Harbour BioMed Recent Developments
  79. 6.14 PolyGene
  80. 6.14.1 PolyGene Company Information
  81. 6.14.2 PolyGene Business Overview
  82. 6.14.3 PolyGene Genetically Modified Animal Models Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 PolyGene Genetically Modified Animal Models Product Portfolio
  84. 6.14.5 PolyGene Recent Developments
7 North America
  1. 7.1 North America Genetically Modified Animal Models Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Genetically Modified Animal Models Market Size by Country (2021-2026)
  3. 7.3 North America Genetically Modified Animal Models Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Genetically Modified Animal Models Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Genetically Modified Animal Models Market Size by Country (2021-2026)
  3. 8.3 Europe Genetically Modified Animal Models Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Genetically Modified Animal Models Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Genetically Modified Animal Models Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Genetically Modified Animal Models Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Genetically Modified Animal Models Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Genetically Modified Animal Models Market Size by Country (2021-2026)
  3. 10.3 South America Genetically Modified Animal Models Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Genetically Modified Animal Models Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Genetically Modified Animal Models Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Genetically Modified Animal Models Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research